Blog
Christopher R. McCurdy, Ph.D., FAAPS, is a broadly trained medicinal chemist, behavioral pharmacologist and pharmacist whose research focuses on the design, synthesis and development of drugs to treat pain and drug abuse.
For over 20 years, much of his research has focused on opioid, Neuropeptide FF and sigma receptor ligand/probe design, synthesis, pharmacological evaluation and development. He has been successful in discovering unique and selective tools for sigma receptors, NPFF receptors and opioid receptors. He is an internationally recognized expert on Kratom (Mitragyna speciosa), that is under investigation for opioid withdrawal syndrome.
Our tireless pursuit for superior quality is one of the crucial characteristics that sets ETHA apart. We continue to go beyond basic standards and minimum requirements to be the very best kratom manufacturer. Our Research and Development (R&D) team never stops working on new concepts, products and projects.
Continue reading